Core Viewpoint - Safety Shot, Inc. has announced a registered direct offering and concurrent private placement to raise approximately $16.3 million, which will strengthen its balance sheet and support its operations following the recent merger approval with Yerbaé [1][3][5]. Group 1: Offering Details - The company is offering 22,993,492 shares of common stock at a price of $0.461 per share [1]. - In addition, warrants to purchase up to 45,986,984 shares of common stock have been issued, with a purchase price of $0.125 per warrant and an exercise price of $0.461 per share [2]. - The gross proceeds from both the registered direct offering and the private placement are expected to be around $16.3 million before fees and expenses [3]. Group 2: Strategic Importance - The CEO of Safety Shot emphasized that this financing is crucial for the company at a pivotal time, enhancing the balance sheet and providing necessary capital for daily operations and integration post-merger [5]. - The company aims to accelerate its commercial footprint and drive long-term value for shareholders with this capital infusion [5]. Group 3: Regulatory Information - The shares are being offered under a shelf registration statement filed with the SEC, which was declared effective on November 9, 2022 [4]. - A prospectus supplement detailing the terms of the offering will be filed with the SEC and made available on their website [4]. Group 4: Company Overview - Safety Shot, Inc. specializes in wellness and dietary supplements, with its flagship product, Sure Shot, designed to lower blood alcohol content while enhancing clarity and mood [7]. - The product is available for purchase on various online platforms, including Walmart and Amazon [7].